Hudson Bay Capital Management
COEPW

Hudson Bay Capital Management’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Hudson Bay Capital Management’s Portfolio COEPW Stock Details COEPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-90,962
Closed -$49K – 1010
2021
Q2 		$49K Buy
+90,962
New +$46.3K ﹤0.01% 907

Other funds holding COEPW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $469M AUM 32.23% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Hudson Bay Capital Management's COEPW Position: Q3 2021 in Review

Hudson Bay Capital Management sold out of Coeptis Therapeutics Warrants (COEPW) in Q3 2021, closing a stake of 90,962 shares — an estimated $49K sold.

Hudson Bay Capital Management first reported a position in COEPW in Q2 2021 and held it in 1 quarter. The position peaked at $49K in Q2 2021. 20 funds tracked by Wall St. Rank hold COEPW as of Q3 2021.

  • Hudson Bay Capital Management reported no remaining Coeptis Therapeutics Warrants position as of Q3 2021 after selling out during the quarter.
  • Hudson Bay Capital Management sold 90,962 Coeptis Therapeutics Warrants shares in Q3 2021, an estimated $49K.
  • Hudson Bay Capital Management first reported a position in Coeptis Therapeutics Warrants in Q2 2021 and held it in 1 quarter.
  • Hudson Bay Capital Management's Coeptis Therapeutics Warrants position peaked at $49K in Q2 2021.
  • 20 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q3 2021.

Based on Hudson Bay Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.